Page last updated: 2024-08-24

3-iodobenzylguanidine and Cardiac Toxicity

3-iodobenzylguanidine has been researched along with Cardiac Toxicity in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Arrais, TR; Biolo, A; Cavalli, GD; Dos Santos, BT; Grossman, GB; Migliavaca, CB; Pereira, GB1
Verberne, HJ; Verschure, DO1
Amanullah, A; Gupta, S1
Andrade, LR; Brandão, SC; Guimarães, SL; Maia, RJ; Markman Filho, B1
Aragon, DC; da Rocha, ET; da Silva, ET; Dos Santos, MJ; Junior, JS; Verberne, HJ1
Elming, MB; Hasbak, P; Hutchings, M; Kjaer, A; Laursen, AH; Ripa, RS; Thune, JJ1

Reviews

3 review(s) available for 3-iodobenzylguanidine and Cardiac Toxicity

ArticleYear
MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:5

    Topics: 3-Iodobenzylguanidine; Anthracyclines; Cardiotoxicity; Heart; Humans; Stroke Volume; Ventricular Function, Left

2022
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
    Heart failure reviews, 2015, Volume: 20, Issue:2

    Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotoxicity; Death, Sudden, Cardiac; Ephedrine; Heart; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Prognosis; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon

2015
    Clinical physiology and functional imaging, 2018, Volume: 38, Issue:2

    Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotoxicity; Early Diagnosis; Heart; Humans; Iodine Radioisotopes; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left

2018

Other Studies

3 other study(ies) available for 3-iodobenzylguanidine and Cardiac Toxicity

ArticleYear
Anthracycline-induced cardiotoxicity: Is there a role for myocardial
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:3

    Topics: 3-Iodobenzylguanidine; Anthracyclines; Cardiotoxicity; Doxorubicin; Humans; Iodine Radioisotopes; Lymphoma; Radionuclide Imaging

2020
Cardiac sympathetic hyperactivity after chemotherapy: early sign of cardiotoxicity?
    Arquivos brasileiros de cardiologia, 2015, Volume: 105, Issue:3

    Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Aged; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Cardiotoxicity; Echocardiography, Doppler; Female; Heart; Heart Diseases; Heart Rate; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Statistics, Nonparametric; Stroke Volume; Sympathetic Nervous System; Trastuzumab

2015
Assessment of late anthracycline-induced cardiotoxicity by
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:1

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Autonomic Nervous System Diseases; Brazil; Cardiotoxicity; Causality; Child; Child, Preschool; Comorbidity; Female; Humans; Male; Neoplasms; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left

2017